These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22446977)

  • 1. Hypothesis: butyrate is not an HDAC inhibitor, but a product inhibitor of deacetylation.
    Corfe BM
    Mol Biosyst; 2012 Jun; 8(6):1609-12. PubMed ID: 22446977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule.
    Chriett S; Dąbek A; Wojtala M; Vidal H; Balcerczyk A; Pirola L
    Sci Rep; 2019 Jan; 9(1):742. PubMed ID: 30679586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways.
    Aoyama M; Kotani J; Usami M
    Nutrition; 2010 Jun; 26(6):653-61. PubMed ID: 20004081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.
    Chen JS; Faller DV
    J Cell Physiol; 2005 Jan; 202(1):87-99. PubMed ID: 15389542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
    Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone-deacetylase inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts.
    Waldecker M; Kautenburger T; Daumann H; Veeriah S; Will F; Dietrich H; Pool-Zobel BL; Schrenk D
    Nutrition; 2008 Apr; 24(4):366-74. PubMed ID: 18262392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():77-82. PubMed ID: 15947489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.
    Khan S; Jena G
    Epigenomics; 2015; 7(4):669-80. PubMed ID: 26111036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation.
    Ohata A; Usami M; Miyoshi M
    Nutrition; 2005; 21(7-8):838-47. PubMed ID: 15975492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
    Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
    Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.
    Dagtas AS; Edens RE; Gilbert KM
    Int Immunopharmacol; 2009 Oct; 9(11):1289-97. PubMed ID: 19664724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glycosylation pathways and the cell cycle: sugar-dependent activity of butyrate-carbohydrate cancer prodrugs.
    Sampathkumar SG; Jones MB; Meledeo MA; Campbell CT; Choi SS; Hida K; Gomutputra P; Sheh A; Gilmartin T; Head SR; Yarema KJ
    Chem Biol; 2006 Dec; 13(12):1265-75. PubMed ID: 17185222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the histone deacetylase inhibitor sodium butyrate on the viability and life span in Drosophila melanogaster].
    Vaĭserman AM; Koliada AK; Koshel' NM; Simonenko AV; Pasiukova EG
    Adv Gerontol; 2012; 25(1):126-31. PubMed ID: 22708457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination.
    Koprinarova M; Botev P; Russev G
    DNA Repair (Amst); 2011 Sep; 10(9):970-7. PubMed ID: 21824827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of butyrate analogues in HT-29 cancer cells.
    Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the Role of the Microbiota and of Short-Chain Fatty Acids in Rubinstein-Taybi Syndrome.
    Di Fede E; Ottaviano E; Grazioli P; Ceccarani C; Galeone A; Parodi C; Colombo EA; Bassanini G; Fazio G; Severgnini M; Milani D; Verduci E; Vaccari T; Massa V; Borghi E; Gervasini C
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone-deacetylase-inhibitory effects of periodontopathic-bacterial metabolites induce human gingival epithelial Ca9-22 cell death.
    Uemichi K; Mikami Y; Watanabe T; Shinozuka K; Tonogi M; Tsuda H
    Odontology; 2023 Jul; 111(3):658-667. PubMed ID: 36482237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats.
    Soret R; Chevalier J; De Coppet P; Poupeau G; Derkinderen P; Segain JP; Neunlist M
    Gastroenterology; 2010 May; 138(5):1772-82. PubMed ID: 20152836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.